Products atomoxetine + placebo
atomoxetine + placebo Pre-clinical Completed 💤 Quiet Menopause, Cognitive Disturbances
May 1, 2004 → Apr 1, 2008
About atomoxetine + placebo atomoxetine + placebo is a pre-clinical stage product being developed by Eli Lilly for Menopause. The current trial status is completed. This product is registered under clinical trial identifier NCT00611533. Target conditions include Menopause, Cognitive Disturbances.
Clinical Trials (13) NCT ID Phase Status Start Completion Indication NCT00962104 Phase 3 Completed Aug 1, 2009 Feb 1, 2011 Attention Deficit Hyperactivity Disorder NCT00716274 Approved Completed Sep 1, 2008 Jul 1, 2016 Attention Deficit Hyperactivity Disorder NCT00607919 Approved Completed Mar 1, 2008 Feb 1, 2011 Attention Deficit Hyperactivity Disorder NCT00546910 Approved Completed Oct 1, 2007 May 1, 2009 Attention Deficit Hyperactivity Disorder NCT00617201 Phase 2 Completed Jul 1, 2007 Aug 1, 2011 Substance Abuse NCT00406354 Approved Completed Nov 1, 2006 Jan 1, 2009 Attention Deficit Hyperactivity Disorder NCT00380692 Approved Completed Oct 1, 2006 Oct 1, 2008 Autistic Disorder NCT00260533 Phase 2/3 Completed Nov 1, 2005 Jul 1, 2008 Generalized Social Phobia NCT00191542 Phase 3 Completed Mar 1, 2005 Aug 1, 2006 Attention Deficit Hyperactivity Disorder NCT00191295 Phase 2/3 Completed Feb 1, 2005 Sep 1, 2006 Attention Deficit Hyperactivity Disorder NCT00190957 Approved Completed Aug 1, 2004 Jan 1, 2006 ADHD NCT00386581 Phase 3 Completed Jul 1, 2004 Feb 1, 2005 Attention Deficit Disorder With Hyperactivity NCT00611533 Pre-clinical Completed May 1, 2004 Apr 1, 2008 Menopause
Product Company Stage Hype Score Fezolinetant + Placebo Astellas Pharma Phase 2 Cetrorelix Shionogi Pre-clinical Teriparatide (PTH 1-34) Eli Lilly Phase 2/3 Eszopiclone + Placebo Sumitomo Pharma Pre-clinical Comparator: placebo + Comparator: Estrace Merck Phase 1 esmirtazapine + Placebo Merck Phase 3 Marketed low dose hormone replacement therapy Novo Nordisk Pre-clinical 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) Novo Nordisk Pre-clinical 1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA) Novo Nordisk Approved estradiol, 10 mcg + estradiol, 25 mcg + placebo Novo Nordisk Phase 3 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) + 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA) + 1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA) Novo Nordisk Phase 1 estradiol, 25 mcg Novo Nordisk Pre-clinical estradiol, 10 mcg Novo Nordisk Phase 3 estradiol, 10 mcg + estradiol, 25 mcg Novo Nordisk Phase 1 estradiol, 10 mcg Novo Nordisk Phase 3 2 mg estradiol / 1 mg norethisterone acetate (NETA) Novo Nordisk Phase 1 estradiol, 25 mcg Novo Nordisk Phase 3 estradiol, 25 mcg Novo Nordisk Phase 3 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) + 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA) + placebo Novo Nordisk Phase 3 estradiol, 25 mcg + estradiol, 25 mcg Novo Nordisk Phase 1
Other Products from Eli Lilly